NDC 83881-0401-30 — LidoPro Patch Lidocaine, Menthol, and Methyl

🆔 Identity & classification

FDA NDC (as labeled) 83881-401-30

Product NDC 83881-401

11-digit billing NDC 83881040130

NCPDP billing unit EA — each (per item)

RxCUI 2675022, 2675024

UNII 98PI200987, L7T10EIP3A, LAV5U5022Y

UPC 0383881401303, 0383881401020

Application # M017

SPL Set ID 10f98011-bffc-cc56-e063-6394a90a0116

Established class (EPC) Amide Local Anesthetic; Antiarrhythmic

Physiologic effect Local Anesthesia

Chemical class Amides

DEA schedule Non-controlled

Marketing category OTC MONOGRAPH DRUG

Marketing status Discontinued

FDA listing status Discontinued by firm (certified through Aug 2026)

Marketing start 2024-02-09

Route TOPICAL

Dosage form PATCH

Substance LIDOCAINE; MENTHOL; METHYL SALICYLATE

GCN Seq No 085794

GCN 55351

HICL code 041614

Ingredient (HICL) Lidocaine/Methyl Sal/Menthol

HIC1 code Q

Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other

HIC2 code Q5

Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin

HIC3 code Q5H

Therapeutic class — specific (HIC3) Topical Local Anesthetics

AHFS code 72:00.00.00

AHFS class Local Anesthetics

FDB label name LIDOPRO 4%-0.5%-0.1% PATCH

FDB brand name Lidopro Patch

Legend status O — Over-the-counter (OTC) drug or device

Why two NDCs? The FDA registers this code as 83881-401-30 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 83881-0401-30. Same drug, same package — only the format differs.

Where does this data come from?

Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerClinic Pharma

FDA applicationM017 (OTC MONOGRAPH DRUG)

Labeler code83881

First marketedFeb 2024

Product typeHuman Otc Drug

Portfolio9 products on file

🔎 All NDCs from Clinic Pharma

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).

Where does this data come from?

Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name LIDOPRO 4%-0.5%-0.1% PATCH Ingredient Lidocaine/Methyl Sal/Menthol

🧪 What is this product?

LidoPro Patch is a topical patch sold over the counter under FDA's OTC monograph rules. It contains lidocaine, a local anesthetic, along with menthol and methyl salicylate, which are commonly used in topical pain-relief products for their warming and cooling sensations. Together, these ingredients are typically used in patches applied to the skin for temporary relief of minor aches and pains in muscles and joints.

Patient education

📘 MedlinePlus patient leaflet ↗

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →

Where does this data come from?

Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

We could not link this NDC to a current FDA Structured Product Label. An inactive-ingredient list is therefore not available from this source.

Where does this data come from?

Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?

No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.

Why might an inactive ingredient be missing?

Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.

Can inactive ingredients matter?

Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price system	Per each	Per package
Retail pharmacies payNADAC · weekly	Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo	No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly	No Part D plan price is available for this NDC in our data.

ℹ️

No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.

Try another pack size: 2 patches

Where does this data come from?

NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

Product	Labeler	Pack	NADAC/unit	TE	Status	Price vs. this
LidoPro Patch 4 mg/100mg; .5 mg/100mg; .1 mg/100mg 68788-8594-03	Preferred	30 patches	—	—	FDA listed	—
LidoPro Patch 4 mg/100mg; .5 mg/100mg; .1 mg/100mg 80425-0374-01	Advanced	30 patches	—	—	FDA listed	—
LidoPro Patch 4 mg/100mg; .5 mg/100mg; .1 mg/100mgthis 83881-0401-30	Clinic	30 patches	—	—	Discontinued	—

About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.

Where does this data come from?

Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️

2024

On the market since

Feb 2024

📍

2026

Currently FDA-listed

2 years listed

🔒

·

No generic listed yet

brand only

ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?

Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDC	Description	Marketing start	Status
83881-0401-02	2 PATCH in 1 POUCH (83881-401-02) / 8500 mg in 1 PATCH	2024-02-09	Discontinued by firm
83881-0401-30 You're viewing this	15 POUCH in 1 BOX (83881-401-30) / 2 PATCH in 1 POUCH / 8500 mg in 1 PATCH	2024-02-09	Discontinued by firm

Pack size FAQ

What quantity is in NDC 83881-0401-30?

NDC 83881-0401-30 is listed by the FDA — 15 pouch in 1 box / 2 patch in 1 pouch / 8500 mg in 1 patch.

What NDC number is used to bill for this package of LidoPro Patch Lidocaine, Menthol, and Methyl Salicylate 4 mg/100mg; .5 mg/100mg; .1 mg/100mg Patch?

Bill NDC 83881-0401-30 — the 11-digit billing format is 83881040130. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)

What data is (and isn’t) available for this NDC — tap to expand

NDC identity (package / product / labeler codes)	✓ Available
Labeler	✓ Available
Product & package description	✓ Available
Marketing category & status	✓ Available
Active ingredient / dosage form / route	✓ Available
FDA label (SPL via DailyMed)	✓ Available
Package photos	— Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured)	— Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS)	— Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data	— Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk	— Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD)	— Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.

“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?

An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.

Why is there no price listed?

The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.

What does the discontinued status mean for this NDC?

The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.

Is the NDC printed on the package the same as the 11-digit billing NDC?

Yes, they identify this exact package in different formats. The FDA registers it as 83881-401-30, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 83881-0401-30, written without dashes as 83881040130. The Identity section at the top of this page lists every form of this code.

What do the three segments of this NDC mean?

In 83881-0401-30, the first segment (83881) is the labeler code FDA assigned to Clinic Pharma; the middle segment (0401) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (30) identifies this exact package size and type. Together they name one specific package of one specific product.

Does this product come in other package sizes?

Yes — the FDA directory lists 1 other package presentation of this same product, including 2 patches (83881-0401-02). Each has its own NDC and its own page — see the package list near the top of this page.

Who lists this product with the FDA?

Clinic Pharma is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.

Do I need a prescription for this product?

This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.

This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.

Where does this data come from?

Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.

🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose

🎯 Indications and Usage 5 words ▾

Uses Temporarily relieves minor pain

⏱️ Dosage and Administration 58 words ▾

DIRECTIONS ad ults and children over 12 years: clean and dry the affected area remove patch from plastic liner and place on the affected area use 1 patch for up to 12 hours place used patch on the liner when not in use re-use the patch up to 2 times. children 12 years or younger: ask a doctor

⚠️ Warnings 219 words ▾

Warnings For external use only Do not use • more than one patch on your bidy at a time or on cuts, irritated, or swollen skin • on puncture wounds • for more than one week without consulting a doctor. When using this product Use only as directed. Read and follow directions and warning on this packaging.

Do not apply to wounds or damaged, broken, or irritated skin Avoid contact with the eyes or mucous membranes Do not bandage tightly or apply local heat (such as heating pads) to area of use Do not use at the same time as other topical analgesics Dispose of used patch in manner that always keeps product away from children and pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch. Stop use and ask a doctor if conditions worsens redness is present irritation develops symptoms persist for more than 7 days or clear up and occur again within a few days you experience signs of injury, such as pain, swelling, or blistering where the product was applied If pregnant or breast feeding, ask health professional before use.

Keep out of reach of children and pets. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 13 words ▾

Active Ingredient Lidocaine 4%

Active Ingredient Menthol .5%

Active Ingredient Methyl Salicylate .1%

🧪 Inactive Ingredients 8 words ▾

OTHER INGREDIENTS: Vegan Glycerol, Polyacrylate, Aqua. Polysorbate 80

🎯 Purpose 9 words ▾

Purpose Topical Anesthetic

Purpose Topical Analgesic

Purpose Topical Counterirritant

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

🔗 Related NDC lookups

🧪 All Lidocaine, Menthol, And Methyl Salicylate NDCsSame ingredient 🏭 All Clinic labeler NDCsLabeler code 83881 📚 All Amide Local Anesthetic NDCsDrug class

💊 Related drugs in this class

Other drugs that share this product’s specific therapeutic class — Topical Local Anesthetics.

Lidocaine 00121-0970-05 Pramoxine Hcl 00316-0230-75 Dyclonine Hcl 00362-3971-05 Lidocaine Hcl 00536-1139-20 Dibucaine 00536-1211-95 Tetracaine/Benzocaine/Butamben 10223-0201-03 Benzocaine 16864-0640-01 Benzocaine/Benzethon Cl 16864-0670-01 Benzocaine/Menthol 16864-0680-01 Lidocaine/Aloe Vera 46122-0555-28 Lidocaine/Menthol 46122-0574-21 Lidocaine Hcl/Benzalkonium Chl 46122-0656-25 Benzocaine/Resorcinol 63868-0949-01 Dyclonine Hcl/Benzethonium Cl 70000-0599-01

Where does this data come from?

Other drugs sharing this product’s First Databank therapeutic class (HIC3). Each links to that NDC’s page in our directory.